Evidence map›Paper›PMID 34472046›Full record

ArticleInterdisciplinary sciences, computational life sciences2021

Biomarker Identification in Membranous Nephropathy Using a Long Non-coding RNA-Mediated Competitive Endogenous RNA Network.

Guangyu Zhou, Nan Jiang, Wenlong Zhang, Shuojie Guo, Guangda Xin

Abstract read
PubMed Publisher
In one paragraph

Article in Interdisciplinary sciences, computational life sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Guangyu ZhouDepartment of Nephrology, China-Japan Union Hospital of Jilin University, No. 126, Xian Tai Street, Changchun, 130033, Jilin, China.
Nan JiangDepartment of Emergency, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Wenlong ZhangDepartment of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Shuojie GuoDepartment of Nephrology, China-Japan Union Hospital of Jilin University, No. 126, Xian Tai Street, Changchun, 130033, Jilin, China.
Guangda XinDepartment of Nephrology, China-Japan Union Hospital of Jilin University, No. 126, Xian Tai Street, Changchun, 130033, Jilin, China. xingd@jlu.edu.cn.
Jilin University · CN

Funding

Special Project for Health Research of jilin Province 2020SCZ37the Science and Technology Development Plan Project of Jilin Province 20200201383JCthe Science and Technology Development Plan Project of Jilin Province 20200201437JC
6 · The paper itself

Abstract

purposeThis study was aimed to identify biomarker associated with membranous nephropathy (MN) progression by integration of expression profiles and competitive endogenous RNA (ceRNA) network analysis.

methodsThe gene (GSE108113) and microRNAs (miRNAs) expression profiles (GSE64306) were downloaded to identify the differentially expressed mRNAs, miRNAs and long non-coding RNAs (lncRNAs) between MN and control groups. The functions and pathways enriched by the differentially expressed mRNAs were analyzed. The mRNA-lncRNA co-expression network was constructed followed by and the ceRNA network construction.

resultsTotal 264 upregulated and 196 downregulated differentially expressed mRNAs, 79 upregulated and 4 downregulated lncRNAs, as well as 115 upregulated and 93 downregulated miRNAs were obtained between MN and control groups. After analysis, the differential mRNAs were significantly involved in multiple immune-related processes, and cell proliferation, apoptosis and differentiation processes, as well as pathways of taste transduction and lysosome. Finally, a ceRNA network consisting of 4 mRNAs (EPB41L5, FAM43A, PRKG1 and TTC14), 3 lncRNAs (LINC00052, LINC00641 and N4BP2L2-IT2) and 5 miRNAs (hsa-miR-145-5p, hsa-miR-3605-5p, hsa-miR-148a-3p, hsa-miR-497-5p and hsa-miR-148b-3p) was constructed.

conclusionOur study indicated dysregulation of immune- and apoptosis-associated functions and taste transduction and lysosome pathways may play important roles in MN progression. Deregulated ceRNAs, such as LINC00052-hsa-miR-145-5p-EPB41L5, LINC00052-hsa-miR-148a-3p-FAM43A and LINC00641-hsa-497-5p-PRKG1, may be associated with MN development.

Indexed as

Glomerulonephritis, MembranousMicroRNAsRNA, Long NoncodingBiomarkersGene Regulatory NetworksHumansMembrane ProteinsRNA, MessengerBiomarkersMembrane ProteinsMicroRNAsRNA, Long NoncodingRNA, MessengerCompetitive endogenous RNAGene expression profilelncRNAMembranous nephropathymiRNA

Identifiers

PMID34472046
OpenAlexW3196606596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.